Peru vs Russian Federation: The number of people with susceptibility test result for rifampicin
Peru
94.02
in 2021
Russian Federation
93.52
in 2021
Peru rank
55th
Russian Federation rank
57th
The number of people with susceptibility test result for rifampicin over time
- Peru
- Russian Federation
How they compare
Peru currently reports 94.02 against 93.52 in Russian Federation, a difference of 0.5.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Russian Federation ahead.
Peru ranks 55th and Russian Federation ranks 57th of 146 countries.
Russian Federation has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Peru | Russian Federation | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 76.94 | 88.47 | 11.53 | Russian Federation |
| 2020s | 82.99 | 93.01 | 10.01 | Russian Federation |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Peru or Russian Federation?
- Peru, at 94.02 against 93.52 in Russian Federation as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Peru and Russian Federation?
- 0.5, with Peru ahead.
- How many years of comparable data are there for Peru and Russian Federation?
- 5 years are reported by both, from 2017 to 2021.
- How do Peru and Russian Federation rank globally for the number of people with susceptibility test result for rifampicin?
- Peru ranks 55th and Russian Federation ranks 57th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.